Hudson Valley Investment Advisors Inc Merck & Co., Inc. Transaction History

Hudson Valley Investment Advisors Inc

$903 Million
Q3 2024

A detailed history of Hudson Valley Investment Advisors Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Hudson Valley Investment Advisors Inc holds 15,818 shares of MRK stock, worth $1.63 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

15,818

Previous 18,423 14.14%

Holding current value

$1.63 Million

Previous $2.28 Million 21.23%

% of portfolio

0.2%

Previous 0.28%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$111.15 - $128.97 $289,545 - $335,966	-2,605 Reduced 14.14%	15,818 $1.8 Million
Q2 2024 Jul 02, 2024	BUY	$123.8 - $132.96 $188,795 - $202,764	1,525 Added 9.02%	18,423 $2.28 Million
Q1 2024 Apr 12, 2024	SELL	$113.24 - $131.95 $172,691 - $201,223	-1,525 Reduced 8.28%	16,898 $2.23 Million
Q4 2023 Jan 12, 2024	SELL	$100.18 - $109.02 $222,399 - $242,024	-2,220 Reduced 10.75%	18,423 $2.01 Million
Q3 2023 Oct 27, 2023	SELL	$102.95 - $114.33 $193,648 - $215,054	-1,881 Reduced 8.35%	20,643 $2.13 Million
Q2 2023 Jul 17, 2023	SELL	$108.61 - $118.38 $215,373 - $234,747	-1,983 Reduced 8.09%	22,524 $2.6 Million
Q1 2023 Apr 06, 2023	SELL	$102.94 - $114.86 $131,454 - $146,676	-1,277 Reduced 4.95%	24,507 $2.61 Million
Q4 2022 Jan 31, 2023	SELL	$87.44 - $112.11 $164,824 - $211,327	-1,885 Reduced 6.81%	25,784 $2.86 Million
Q3 2022 Oct 11, 2022	SELL	$84.53 - $94.96 $213,776 - $240,153	-2,529 Reduced 8.37%	27,669 $2.38 Million
Q2 2022 Jul 18, 2022	SELL	$83.49 - $94.64 $379,462 - $430,138	-4,545 Reduced 13.08%	30,198 $2.75 Million
Q1 2022 Apr 20, 2022	SELL	$73.51 - $82.4 $125,996 - $141,233	-1,714 Reduced 4.7%	34,743 $2.85 Million
Q4 2021 Jan 24, 2022	SELL	$72.28 - $90.54 $69,461 - $87,008	-961 Reduced 2.57%	36,457 $2.79 Million
Q3 2021 Oct 26, 2021	SELL	$71.68 - $78.83 $257,904 - $283,630	-3,598 Reduced 8.77%	37,418 $2.81 Million
Q2 2021 Jul 07, 2021	SELL	$70.31 - $77.77 $432,054 - $477,896	-6,145 Reduced 13.03%	41,016 $3.19 Million
Q1 2021 Apr 23, 2021	SELL	$68.86 - $81.11 $242,869 - $286,074	-3,527 Reduced 6.96%	47,161 $3.64 Million
Q4 2020 Jan 15, 2021	SELL	$71.77 - $79.65 $9,114 - $10,115	-127 Reduced 0.25%	50,688 $4.15 Million
Q3 2020 Oct 13, 2020	BUY	$73.18 - $82.95 $36,370 - $41,226	497 Added 0.99%	50,815 $4.22 Million
Q2 2020 Jul 07, 2020	BUY	$70.42 - $80.13 $37,322 - $42,468	530 Added 1.06%	50,318 $3.89 Million
Q1 2020 Apr 29, 2020	BUY	$63.36 - $87.82 $195,465 - $270,924	3,085 Added 6.61%	49,788 $3.83 Million
Q4 2019 Jan 17, 2020	BUY	$77.58 - $87.54 $183,166 - $206,681	2,361 Added 5.32%	46,703 $4.25 Million
Q3 2019 Oct 18, 2019	BUY	$76.08 - $82.93 $126,673 - $138,078	1,665 Added 3.9%	44,342 $3.73 Million
Q2 2019 Jul 16, 2019	SELL	$69.84 - $81.59 $16,971 - $19,826	-243 Reduced 0.57%	42,677 $3.58 Million
Q1 2019 Apr 10, 2019	SELL	$69.58 - $79.36 $406,486 - $463,621	-5,842 Reduced 11.98%	42,920 $3.57 Million
Q4 2018 Jan 17, 2019	BUY	$65.24 - $75.71 $577,113 - $669,730	8,846 Added 22.16%	48,762 $3.73 Million
Q3 2018 Oct 12, 2018	BUY	$57.69 - $67.84 $6,634 - $7,801	115 Added 0.29%	39,916 $2.83 Million
Q2 2018 Jul 10, 2018	BUY	$50.83 - $59.72 $64,299 - $75,545	1,265 Added 3.28%	39,801 $2.42 Million
Q1 2018 Apr 12, 2018	SELL	$50.96 - $59.23 $79,752 - $92,694	-1,565 Reduced 3.9%	38,536 $2.1 Million
Q4 2017 Jan 16, 2018	SELL	$51.62 - $61.64 $1.28 Million - $1.53 Million	-24,751 Reduced 38.17%	40,101 $2.26 Million
Q3 2017 Oct 13, 2017	BUY	$58.67 - $63.13 $3.8 Million - $4.09 Million	64,852	64,852 $4.15 Million

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Valley Investment Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Hudson Valley Investment Advisors Inc with notifications on news.

Account

Hudson Valley Investment Advisors Inc Merck & Co., Inc. Transaction History